Phage Therapy 2024 Concluding Remarks by Jean-Paul Pirnay: Towards Personalized Phage Therapy

The 7th World Congress on Targeting Phage Therapy 2024 took place on June 20-21 in Malta, attracting over 100 participants from more than 30 countries. The event included over 40 presentations, comprising major talks, short orals, and posters. Dr. Jean Paul Pirnay concluded the conference with remarks emphasizing the critical role of personalized phage therapy…

Jean-Paul Pirnay Wins Best Scientific Contribution at Phage Therapy 2024

The Targeting Phage Therapy 2024 Best Scientific Contribution award was discerned to: Jean-Paul Pirnay, Queen Astrid Military Hospital, Belgium Dr. Pirnay, an active scientific board member, concluded the conference and presented an insightful presentation titled “Magistral Phage Preparations – Is This the Model for Everyone?” In his presentation, Dr. Pirnay explored: 🔹 Phage therapy as…

Engineered M13 Bacteriophage for Cancer Therapy Wins Best Short Oral at Phage Therapy 2024

The Targeting Phage Therapy 2024 Best Short Oral Presentation award (2) was discerned to: Nanobiotechnological Engineering of the M13 Bacteriophage for Targeted Photodynamic Cancer Therapy Alena Kaltenbrunner, University of Bologna, Italy Her study developed recombinant M13 phages displaying nanobodies specific to cancer markers EGFR and Her2, and conjugated with photosensitizers. These engineered phages demonstrated high…

Immune Response to Nebulized Phage Therapy in Cystic Fibrosis Patients Wins Best Short Oral at Phage Therapy 2024

The Targeting Phage Therapy 2024 Best Short Oral Presentation award was discerned to: Neutralizing Antibodies After Nebulized Phage Therapy in Cystic Fibrosis Patients Marco Pardo-Freire, University of Valencia, Spain His research demonstrated that nebulized phage therapy significantly reduces bacterial load in Cystic Fibrosis (CF) patients with lung infections and highlighted the emergence of phage-neutralizing antibodies,…

Phage-Based Tool for Treating Antibiotic-Resistant Gonorrhea Wins Best Poster at Phage Therapy 2024

The Targeting Phage Therapy 2024 Best Poster Presentation award was discerned to: Development of Phage-based Tool with the Potential to Treat Antibiotic-Resistant Gonorrhea Magdalena Pelka, University of Warsaw, Poland Ms. Pelka’s research focused on developing a phage-based tool to treat antibiotic-resistant gonorrhea. Her work involves isolating and characterizing phages with lytic activity against Neisseria gonorrhoeae,…

Abstracts Book of Targeting Phage Therapy 2024 is Now Available

The Targeting Phage Therapy 2024 Abstract Book has been released.  You can now gain access to the abstracts of 40 communications, featuring major talks, short orals, and posters, highlighting advancements in phage therapy. Phage Therapy 2024 Communications You can learn more about the communications in the conference program: www.phagetherapy-site.com/Program. How to Access Abstracts Book Order…

Advances in Phage Therapy and Antimicrobial Strategies: Insights from Oral Presentations 2024

The rising threat of antibiotic-resistant bacterial infections has spurred extensive research into alternative therapeutic strategies. Bacteriophages (phages), viruses that infect bacteria, have emerged as a promising tool in combating resistant pathogens. The recent collection of oral presentations provides a comprehensive overview of the latest advancements in phage therapy and antimicrobial research. Oral Presentation Summaries and…

Selected Poster Presentation – Targeting Phage Therapy 2024

The rising threat of antibiotic-resistant bacterial infections has spurred extensive research into alternative therapeutic strategies. Bacteriophages (phages), viruses that infect bacteria, have emerged as a promising tool in combating resistant pathogens. Poster Summaries and Scientific Impacts 1. Development of Phage-based Tool with the Potential to Treat Antibiotic-Resistant Gonorrhea Magdalena Pelka, University of Warsaw, Poland The…